CHRU de Brest Hôpital Morvan

Brest 29609

2 studies enrolling now · 8 studies all time

What they study most

Advanced Cancer, Alopecia, Areata Alopecia, Atopic Dermatitis, Borderline Resectable Pancreatic Cancer, Brain Tumor, Chemotherapy-induced Peripheral Neuropathy, Chronic Lymphocytic Leukemia, Colon Cancer, Colorectal Cancer, EGFR Gene Mutation, Exon 14 Skipping

Studies at this site

• A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata — Recruiting now
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors — Recruiting now
• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer — Stopped early
• Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) — Stopped early
• LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris — Completed